Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center

Size: px
Start display at page:

Download "Adolescent Hypertension Roles of obesity and hyperuricemia. Daniel Landau, MD Pediatrics, Soroka University Medical Center"

Transcription

1 Adolescent Hypertension Roles of obesity and hyperuricemia Daniel Landau, MD Pediatrics, Soroka University Medical Center

2 Blood Pressure Tables BP standards based on sex, age, and height provide a precise classification of BP according to body size. The revised BP tables now include the 50th, 90th, 95th, and 99th percentiles by sex, age, and height.

3

4 Blood Pressure Levels for Boys by Age and Height Percentile SBP (mmhg) DBP (mmhg) Age BP Percentile of Height Percentile of Height (Year) Percentile 5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th 12 50th th th th

5

6 Tirosh A et al, Hypertension 2010;56:203-9.

7 Baseline Adolescent BP: (Survival=progression to young adulthood HTN) <100/ / / / /85-89 Tirosh A et al, Hypertension 2010;56:203-9.

8 14,187 children & adolescents, seen > 3 times for wellchild care, June Sept 2006, northeast Ohio. Proportion of children and adolescents with > 3 elevated BP measurements with a Dx of HTN or pre- HTN documented in the EMR. Of 507 children and adolescents (3.6%) who had hypertension, only 131 (26%) had a Dx of HTN or pre- HTN documented. Patient age, height, obesity-related diagnoses, and magnitude and frequency of abnormal BP readings all increased the odds of diagnosis.

9 Trends in Antihypertensive Med. Use & BP Control Among US Adults With Hypertension NHANES: Detailed in-person home interviews physical examinations (incl. BP) & labs Have you used prescription drugs in last month? 84% of all reported prescription drugs were obtained from container data. BP measured (X3). If > 140/90 hypertension (n=9421) ( ). Increased trend in the use of any antihypertensivein almost all stratified groups Exception: the youngest age group (18-39) & uninsured Gu et al. Circulation 2012; 126:

10 Gu et al. Circulation 2012; 126:

11

12 Prevalence of Persistent Prehypertension in Adolescents Mean of the 2 nd, 3 rd, & 4 th BP measurements BP status/visit, with up to 3 total visits. Acosta et al (Texas). J Pediatr. 2012;160:

13 Almost 30% of the students had at least one elevated BP measurement significantly influenced by obesity. Acosta et al (Texas). J Pediatr. 2012;160:

14 Bar Dayan et al.

15 Prevalence of CVD risk factors: US adolescents, NHANES, n= 3383 (age yrs), from Overall prevalence: prehtn/ HTN: 14% ; Hi LDL: 22%, Low HDL: 6% No change over time predm/dm: 15% increased from 9% to 23% over time Dose-response increase in the prevalence of each of these CVD risk factors by weight categories May et al., Pediatrics. 2012;129:

16 Prevalence of CVD risk factors: US adolescents, May et al., Pediatrics. 2012;129: HTN Hi. LDL Lo. HDL Pre DM/ DM > 2 risk Factors

17 Sodium Intake & BP Among US Children and Adolescents NHANES Children & adolescents (8-18 yrs) (n = 6235) Sodium intake estimated (multiple 24-hr dietary recalls) Na intake ~ 3387 mg/day. Overweight/obese: 37% Pre-HTN: 11.5%, HTN: 3.4% Each 1000 mg Na/day increased SD score of SBP among all subjects, and higher SDS increase among overweight/obese subjects All within NL BP range Na intake & weight status synergistic effects on risk for pre-htn/htn Yang et al. PEDIATRICS 130: 611-9;2012

18 NHANES Adjusted mean (95% CI) SBP & DBP, US children & adolescents (8-18 yrs), by Na intake quartile and weight status Yang Q et al. Pediatrics 2012;130: by American Academy of Pediatrics

19 Childhood Obesity-HTN: Pathophysiology Disturbances in autonomic function Obese children: HR & BP variability Insulin resistance Weight loss in obese adolescents S- insulin & BP previously salt-sensitive individuals insensitive to hypertensive effects of salt-loading Abnormalities in vascular structure and function. In severely obese Vs controls: lower arterial compliance, distensibility & endothelium-dependent and -independent function. Rocchini et al: max. forearm blood flow & min. forearm vascular resistance in obese improved after weight loss (Hypertension. 1992;19:615 20).

20 Sorof J, J Pediatr 2002

21 Sorof J et al., J Pediatr 2002;140: Bogalusa Heart Study : resting heart rate positively correlated with BP & subscapular skinfold thickness (Am J Epidemiol, 1982)

22 Isolated systolic HTN, obesity, & hyperkinetic hemodynamic states in children Sorof J, J Pediatr 2002

23 C PS Mild OSA MS OSA Horne et al., Pediatrics. 2011;128:e85-92

24 Childhood White coat hypertension (WCH): evidence for end-organ effect 119 consecutive children age (mean age = 13.3 yrs; 65% male) referred for High BP with ABPM WCH = 62 & HTN= 57 RESULTS: Office BP did not differ between the 2 groups, but: Awake & asleep DBP + asleep SBP: lower in the WCH group. On treadmill exercise, maximal SBP exceeded norms: HTN: 63% WCH: 38% Lt Ventricular Mass Index > 95th -tile HTN 59%-90% WCH % CONCLUSIONS: Exaggerated exercise BP and/or increased LVMI in 62% of those subjects with WCH suggest that this diagnosis in children may represent a prehypertensive state. Kavey RE et al. J Pediatr 2007;150:491-7

25 BP tracking correlation coefficients for length of follow-up, adjusted for baseline age Chen, X. et al. Tracking of blood pressure from childhood to adulthood: a systematic review and metaregression analysis. Circulation 2008;117:

26 SBP and DBP tracking correlation coefficients against follow-up period Chen, X. et al. Tracking of blood pressure from childhood to adulthood: a systematic review and metaregression analysis. Circulation 2008;117:

27 Tracking of serum lipids, BP & BMI from childhood to adulthood: the CV Risk in Young Finns Study. Study started in 1980 (age 3-18 yrs) 27-yr f/u in 2007 (age: yrs) n= 2204 Childhood risk factors were significantly correlated with levels in adulthood. Correl. coefficients: Cholesterol & BMI: 0.43 to 0.56 (P <.0001) BP & TG : 0.21 to 0.32 (P <.0001) The best sensitivity and specificity rates were observed in 12- to 18-year-old subjects. Juhola et al., J Pediatr. 2011;159:584-90

28 Hypertension, 2005

29

30 Allopurinol, 200 mg twice daily, or placebo BID, for 4 weeks

31 Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents

32 Sugar Sweetened Beverages, Serum Uric Acid & BP in Adolescents (NHANES) J Pediatr. 2009; 154:

33 Secular trends in BMI & BP among children and adolescents: the Bogalusa Heart Study. 24,092 examinations, n= 11,478 (age: 5-17 yrs), , Bogalusa Heart Study (Louisiana). Obesity prevalence up (6% 17%) during this period. BUT: only small changes were observed in SBP & DBP BMI positively associated with SBP & DBP within each of the 7 examinations controlling for BMI (& other covariates) only ~60% as many children as expected had high BP in Thus: what has ameliorated the expected increase in BP d/t obesity? Freedman DS et al., Pediatrics. 2012;130:e

34 BP Z scores, South Korea, boys & girls, age yrs, 1998 Vs 2007/8. (Korean NHANES) Khang Y, and Lynch J W Circulation 2011;124:

35 Childhood Ideal cardiovascular health (AHA) Simultaneous presence of 4 ideal health behaviors never tried or never smoked a whole cigarette BMI <85th percentile physical activity at goal levels diet consistent with current guideline recommendations AND : 3 ideal health factors Untreated total Chol. <170 mg/dl Untreated BP <90th percentile Untreated fasting plasma glucose <100 mg/dl Index: 0 (worst) 7 (best)

36 Ideal CV Health in childhood and cardiometabolic outcomes in adulthood: the Cardiovascular Risk in Young Finns Study. Cardiovascular health: the presence of both ideal health behaviors and ideal health factors. N=856, (age: yrs) followed up for 21 yrs ( ) Health factors and behaviors in childhood cardiometabolic outcomes in adulthood Ideal CV health metrics in childhood reduced adulthood risk of: HTN (OR 0.66 [ ], P<0.001) Metabolic syndr (0.66 [ ], P<0.001) Hi. LDL (0.66 [ ], P=0.001) High-risk carotid a. IMT (0.75 [ ], P=0.01). Leitinen TT et al., Circulation. 2012;125:

37 Unadjusted (A) & age+sex-adjusted (B) adult carotid IMT in different ideal child cardiovascular health index groups. Copyright American Heart Association Laitinen T T et al. Circulation 2012;125:

38 Prevention Relatively advanced levels of atherosclerosis (fibrous plaques) can be present in adolescents and young adults. Risk factors for plaque extent (PM) & carotid IMT (Bogalusa Heart Study, Finland): Hi. BMI, HTN, Hi. LDL-Chol, Lo. HDL-C, DM, cigarette smoking (Berenson GS, et al. NEJM 1998;338:1650 6) (Juonala M, et al. Circulation. 2010;122:2514). Low-CVD-risk status maintained to age 50 yrs very low future risk of CVD. (Lloyd-Jones DM, et al. Circulation 2006;113:791 8).

39 Childhood Adiposity, Adult Adiposity, and Cardiovascular Risk Factors Data analysis, 4 prospective cohort studies (Finland, Australia, USA ) (n=6328), childhood & adult BMI. Follow-up: ~ 23 yrs. Child obese >>> Adult obese --> Hi. Risk for HTN, dyslipidemia, T2DM, carotid IMT. Child obese >>> adult non obese --> regular risk. Juonala M et al. N Engl J Med 2011;365:

40 CO-ANO CNO-ANO CO-AO CNO-AO

41 Exercise and BP Exercise has been shown to help reduce both SBP & DBP in those with HTN Temporary restriction: only for those athletes who have stage 2 HTN until normal BP is achieved. Dynamic exercise (exerting muscles through joint movement) --> SBP & MAP up, but: DBP & total peripheral resistance- down. In static exercise (exerting muscles without joint movement) --> relatively large intramuscular forces develop without much change in muscle length or joint motion. SBP. MAP & DBP increase significantly, and total peripheral resistance remains essentially unchanged PEDIATRICS Volume 125, Number 6, June 2010

42 תודה

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Association between arterial stiffness and cardiovascular risk factors in a pediatric population + Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro

More information

Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital

Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital Obesity and Hypertension Manish Sinha Evelina London Children s Hospital Manchester 30 th June 2017 Scope of Talk Trends of childhood obesity in the UK Prevalence of hypertension in obese children Pathophysiology

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Page 1. Disclosures. Background. No disclosures

Page 1. Disclosures. Background. No disclosures Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen

More information

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease?

Learning Objectives. Cholesterol and Lipids in Kids: It s a Matter of the Heart. Is Atherosclerosis a Pediatric Disease? Scott J. Soifer, MD Professor and Vice Chair Department of Pediatrics University of California, San Francisco UCSF Benioff Children s Hospital Cholesterol and Lipids in Kids: It s a Matter of the Heart

More information

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA

Sugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular

More information

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD Metabolic Syndrome Across the Life Cycle - Adolescent Joy Friedman MD Disclosures I have no actual or potential conflict of interest in relation to this program or presentation. I will mention off-label

More information

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University

More information

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az

Cardiometabolics in Children or Lipidology for Kids. Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az Cardiometabolics in Children or Lipidology for Kids Stanley J Goldberg MD Diplomate: American Board of Clinical Lipidology Tucson, Az No disclosures for this Presentation Death Risk Approximately 40% of

More information

40% minimum reduction from

40% minimum reduction from 160 Circulatory Disease Mortality Target: Death rates in England 1993-2006 Persons under 75 Death / 100,000 population A fall of 44% over 10 years 140 120 100 80 60 40 20 141.0 84.2 Immortality guaranteed

More information

Evaluation and Treatment of Childhood Obesity

Evaluation and Treatment of Childhood Obesity Evaluation and Treatment of Childhood Obesity Stephen R. Daniels, MD, PhD Department of Pediatrics University of Colorado School of Medicine and Children s Hospital Colorado In 1953, Morris et al compared

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Atherosclerotic cardiovascular disease (CVD) is the number

Atherosclerotic cardiovascular disease (CVD) is the number Recent Advances in Preventive Cardiology and Lifestyle Medicine Reduction of Risk for Cardiovascular Disease in Children and Adolescents Stephen R. Daniels, MD, PhD; Charlotte A. Pratt, PhD, RD; Laura

More information

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN 1980 to 2000: Death rate fell from: 542.9 to 266.8 per 100K men 263.3 to 134.4 per 100K women 341,745 fewer deaths from CHD in 2000 Ford ES, NEJM, 2007 47% from CHD treatments, 44% from risk factor modification

More information

Coronary artery disease (CAD) risk factors

Coronary artery disease (CAD) risk factors Background Coronary artery disease (CAD) risk factors CAD Risk factors Hypertension Insulin resistance /diabetes Dyslipidemia Smoking /Obesity Male gender/ Old age Atherosclerosis Arterial stiffness precedes

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice EuroPRevent 2010 Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice G. De Backer Ghent University Ghent, Belgium May 5-8 2010, Prague Czech Republic G. De

More information

Blood Pressure Measurement (children> 3 yrs)

Blood Pressure Measurement (children> 3 yrs) Blood Pressure Measurement (children> 3 yrs) If initial BP elevated, repeat BP manually 2x and average, then classify Normal BP Systolic and diastolic

More information

Cardiovascular Disease Risk Factors and Associations with Indicators of Body Fat, Diet, and Physical Activity in U.S. Children Ages 6-11

Cardiovascular Disease Risk Factors and Associations with Indicators of Body Fat, Diet, and Physical Activity in U.S. Children Ages 6-11 University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Nutrition & Health Sciences Dissertations & Theses Nutrition and Health Sciences, Department of 2010 Cardiovascular Disease

More information

Is Universal Pediatric Lipid Screening Justified? YES. Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016

Is Universal Pediatric Lipid Screening Justified? YES. Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016 Is Universal Pediatric Lipid Screening Justified? YES Damon Dixon, MD, FAAP Preventative Cardiology March 7 th, 2016 None Disclosures What is a Pediatrician? Pediatrics is the specialty of medical science

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Metabolic Syndrome in Asians

Metabolic Syndrome in Asians Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly

More information

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN

Placebo-Controlled Statin Trials EXPLAINING THE DECREASE IN DEATHS FROM CHD! PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN EXPLAINING THE DECREASE IN PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING THE DECREASE

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Diabetes and Hypertension

Diabetes and Hypertension Diabetes and Hypertension M.Nakhjvani,M.D Tehran University of Medical Sciences 20-8-96 Hypertension Common DM comorbidity Prevalence depends on diabetes type, age, BMI, ethnicity Major risk factor for

More information

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES

CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis

More information

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered

More information

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China

Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

EXS 145 Guidelines for Exercise Testing & Prescription

EXS 145 Guidelines for Exercise Testing & Prescription EXS 145 Guidelines for Exercise Testing & Prescription 11-3-11 Andrew Weiler M.Ed MCCD Adjunct Faculty CGCC Employee Wellness Coordinator SRPMIC Employee Wellness Coordinator Pot & Window LLC Today How

More information

Results/ conclusion. Reference Duration Number subjects. Study description. Limitations of the data. Randomized controlled trial (RCT)

Results/ conclusion. Reference Duration Number subjects. Study description. Limitations of the data. Randomized controlled trial (RCT) (original) Appel, 1997 8 weeks 459 459 ; all received a control SAD for 3 weeks then randomized to (i) control (ii) a diet rich in fruits and veg (FV) or (iii) a combination diet (combo) rich in fruits,

More information

«Πατσζαρκία και Καρδιαγγειακή Νόζος»

«Πατσζαρκία και Καρδιαγγειακή Νόζος» «Πατσζαρκία και Καρδιαγγειακή Νόζος» Δημήτρης Π. Παπαδόπουλος-FESC Clinical Assist. Professor George Washington University USA Επιμελητής Καρδιολογικής Κλινικής Π.Γ.Ν.Α. «ΛΑΪΚΟ» Υπεύθυνος Αντιυπερτασικού

More information

Stroke: Prevention is the Best Medicine

Stroke: Prevention is the Best Medicine Stroke: Prevention is the Best Medicine Donna Lindsay, MN, RN, CNS-BC, SCRN Neuroscience Clinical Nurse Specialist/ Stroke Program Coordinator Hennepin Stroke Center Stroke Statistics Approximately 795,000

More information

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center

Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center Branko N Huisa M.D. Assistant Professor of Neurology UNM Stroke Center THE END! CHANGABLE Blood pressure Diabetes Mellitus Hyperlipidemia Atrial fibrillation Nicotine Drug abuse Life style NOT CHANGABLE

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk

More information

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography

Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,

More information

Placebo-Controlled Statin Trials Prevention Of CVD in Women"

Placebo-Controlled Statin Trials Prevention Of CVD in Women MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults

Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen

More information

Background. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C.

Background. Metabolic syndrome T2DM CARDIOVASCULAR DISEASE. Major Unmet Clinical Need. Novel Risk Factors. Classical Risk Factors LDL-C. The effect of metabolic syndrome for left ventricular geometry, arterial stiffness and carotid intima-media thickness in Korean general population Result from Atherosclerosis RIsk of Rural Area in Korea

More information

Web appendix: Supplementary material. Contents

Web appendix: Supplementary material. Contents Web appendix: Supplementary material Contents Appendix 1. Search terms... 2 Appendix 2.1. Parameters measured in studies included in the descriptive-analysis... 3 Appendix 2.2. Parameters measured in studies

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Dr Doris M. W Kinuthia

Dr Doris M. W Kinuthia Dr Doris M. W Kinuthia Objectives Normal blood pressures in children Measurement of blood pressure in children Aetiology of Hypertension in children Evaluation of children with hypertension Treatment of

More information

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313) University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,

More information

Cardiovascular Disease Prevention: Current Knowledge, Future Directions

Cardiovascular Disease Prevention: Current Knowledge, Future Directions Cardiovascular Disease Prevention: Current Knowledge, Future Directions Daniel Levy, MD Director, Framingham Heart Study Professor of Medicine, Boston University School of Medicine Editor-in-Chief, Journal

More information

Heart Disease Genesis

Heart Disease Genesis Heart Disease Genesis The Ultimate Lecture on CAD origins Petr Polasek MD FRCPC FACC Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,

More information

Long-Term Complications of Diabetes Mellitus Macrovascular Complication

Long-Term Complications of Diabetes Mellitus Macrovascular Complication Long-Term Complications of Diabetes Mellitus Macrovascular Complication Sung Hee Choi MD, PhD Professor, Seoul National University College of Medicine, SNUBH, Bundang Hospital Diabetes = CVD equivalent

More information

Fasting or non fasting?

Fasting or non fasting? Vascular harmony Robert Chilton Professor of Medicine University of Texas Health Science Center Director of Cardiac Catheterization labs Director of clinical proteomics Which is best to measure Lower continues

More information

BIOPHYSICAL PROFILE OF BLOOD PRESSURE IN SCHOOLCHILDREN

BIOPHYSICAL PROFILE OF BLOOD PRESSURE IN SCHOOLCHILDREN BIOPHYSICAL PROFILE OF BLOOD PRESSURE IN SCHOOLCHILDREN M. Verma J. Chhatwal S.M. George ABSTRACT The study was conducted in an industrial and prosperous city of Punjab to evaluate the biophysical profile

More information

Importance of Ambulatory Blood Pressure Monitoring in Adolescents

Importance of Ambulatory Blood Pressure Monitoring in Adolescents Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Juonala M, Magnussen C, Berenson G, et al. Childhood adiposity,

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

Atherosclerotic cardiovascular disease remains the leading

Atherosclerotic cardiovascular disease remains the leading AHA Scientific Statement American Heart Association Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease Beginning in Childhood Rae-Ellen W. Kavey, MD; Stephen R. Daniels, MD, PhD;

More information

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension. 2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature

More information

Cardiometabolic Side Effects of Risperidone in Children with Autism

Cardiometabolic Side Effects of Risperidone in Children with Autism Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin

More information

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES

Placebo-Controlled Statin Trials MANAGEMENT OF HIGH BLOOD CHOLESTEROL MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF HIGH BLOOD CHOLESTEROL: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest

More information

Sleep Apnea: Vascular and Metabolic Complications

Sleep Apnea: Vascular and Metabolic Complications Sleep Apnea: Vascular and Metabolic Complications Vahid Mohsenin, M.D. Professor of Medicine Yale University School of Medicine Director, Yale Center for Sleep Medicine Definitions Apnea: Cessation of

More information

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD

More information

The rates of both type 1 diabetes mellitus (T1DM) and type

The rates of both type 1 diabetes mellitus (T1DM) and type AHA Scientific Statement Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus A Scientific Statement From the American Heart Association David M. Maahs, MD, PhD, Co-Chair; Stephen R. Daniels,

More information

Health Benefits of Lowering Sodium Intake in the US

Health Benefits of Lowering Sodium Intake in the US Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology

More information

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines

Conflict of Interest Disclosure. Learning Objectives. Learning Objectives. Guidelines. Update on Lifestyle Guidelines Conflict of Interest Disclosure Updates for the Ambulatory Care Pharmacist: Dyslipidemia and CV Risk Assessment No conflicts of interest to disclose 2014 Updates to the Updates in Ambulatory Care Pharmacy

More information

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer

Case Presentation. Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation Rafael Bitzur The Bert W Strassburger Lipid Center Sheba Medical Center Tel Hashomer Case Presentation 50 YO man NSTEMI treated with PCI 1 month ago Medical History: Obesity: BMI 32,

More information

Comparison of Abnormal Cholesterol in Children, Adolescent & Adults in the United States, : Review

Comparison of Abnormal Cholesterol in Children, Adolescent & Adults in the United States, : Review European Journal of Environment and Public Health, 2017, 1(1), 04 ISSN: 2468-1997 Comparison of Abnormal Cholesterol in Children, Adolescent & Adults in the United States, 2011-2014: Review Rasaki Aranmolate

More information

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES

RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet

More information

Update on CVD and Microvascular Complications in T2D

Update on CVD and Microvascular Complications in T2D Update on CVD and Microvascular Complications in T2D Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of Miami Miller School of Medicine

More information

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes? Boston, MA November 7, 213 Edward S. Horton, MD Professor of Medicine Harvard Medical School Senior Investigator

More information

Obesity Prevention and Control: Provider Education with Patient Intervention

Obesity Prevention and Control: Provider Education with Patient Intervention Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist

More information

MOLINA HEALTHCARE OF CALIFORNIA

MOLINA HEALTHCARE OF CALIFORNIA MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

The association of blood pressure with body mass index and waist circumference in normal weight and overweight adolescents

The association of blood pressure with body mass index and waist circumference in normal weight and overweight adolescents Original article Korean J Pediatr 2014;57(2):79-84 pissn 1738-1061 eissn 2092-7258 Korean J Pediatr The association of blood pressure with body mass index and waist circumference in normal weight and overweight

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management

Center for healthy weight and Nutrition. Primary Care Pocket Guide to. Pediatric Obesity Management Center for healthy weight and Nutrition Primary Care Pocket Guide to Pediatric Obesity Management Introduction The Primary Care Pocket Guide to Pediatric Obesity Management is intended to provide primary

More information

Short stature is an inflammatory disadvantage among middle-aged Japanese men

Short stature is an inflammatory disadvantage among middle-aged Japanese men Environ Health Prev Med (2016) 21:361 367 DOI 10.1007/s12199-016-0538-y REGULAR ARTICLE Short stature is an inflammatory disadvantage among middle-aged Japanese men Yuji Shimizu 1,2 Hiroyuki Yoshimine

More information

Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China

Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China J. Zhang 1, Y.T. Ma 1, X. Xie 1, Y.N. Yang 1, F. Liu 2, X.M. Li 1, Z.Y. Fu 1, X. Ma 1, B.D. Chen 2, Y.Y. Zheng 1,

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of

More information

We have recently published blood pressure (BP) percentiles

We have recently published blood pressure (BP) percentiles Blood Pressure Differences by Ethnic Group Among United States Children and Adolescents Bernard Rosner, Nancy Cook, Ron Portman, Steve Daniels, Bonita Falkner Abstract Large differences in blood pressure

More information

Prevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine

Prevention of complications: are we winning or losing the battle. Naveed Sattar Professor of Metabolic Medicine Prevention of complications: are we winning or losing the battle Naveed Sattar Professor of Metabolic Medicine Duality of Interest Declaration Consultant or speaker for: Amgen, AstraZeneca, Boehringer

More information

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h

1/14/2013 Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of h Pediatric Cardiovascular Disease and the Future of our Children Linda Alwine FNP-BC Objectives Identify the prevalence and epidemiology of hyperlipidemia. Identify risk factors that lead to the development

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Young high risk patients the role of statins Dr. Mohamed Jeilan

Young high risk patients the role of statins Dr. Mohamed Jeilan Young high risk patients the role of statins Dr. Mohamed Jeilan KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

5/28/2010. Pre Test Question

5/28/2010. Pre Test Question Myth of Metabolic Syndrome? C. W. Spellman, DO, PhD Professor and Associate Dean Research Dir. Center Diabetes and Metabolic Disorders Department Internal Medicine, Div. Endocrinology Texas Tech University

More information

Treating Hypertension in 2018: What Makes the Most Sense Today?

Treating Hypertension in 2018: What Makes the Most Sense Today? Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or

More information

Hypertension Guidelines 2017

Hypertension Guidelines 2017 Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram

Dyslipidaemia. Is there any new information? Dr. A.R.M. Saifuddin Ekram Dyslipidaemia Is there any new information? Dr. A.R.M. Saifuddin Ekram PhD,FACP,FCPS(Medicine) Professor(c.c.) & Head Department of Medicine Rajshahi Medical College Rajshahi-6000 New features of ATP III

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK

Examining the relationship between beverage intake and cardiovascular health. Ian Macdonald University of Nottingham UK Examining the relationship between beverage intake and cardiovascular health Ian Macdonald University of Nottingham UK Outline Assessment of evidence in relation to health risks of dietary components Cardiovascular

More information

Approach to Dyslipidemia among diabetic patients

Approach to Dyslipidemia among diabetic patients Approach to Dyslipidemia among diabetic patients Farzad Hadaegh, MD, Professor of Internal Medicine & Endocrinology Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences

More information

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community International Journal of Scientific and Research Publications, Volume 4, Issue 4, April 214 1 The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community Mulugeta

More information